Pure Global

Optimising self-management in people living with chronic kidney disease (CKD:) The Kidney Health 4 Life program - Trial ANZCTR12623000601639

Access comprehensive clinical trial information for ANZCTR12623000601639 through Pure Global AI's free database. This Not Applicable trial is sponsored by Kidney Health Australia and is currently Recruiting. The study focuses on Chronic Kidney Disease.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ANZCTR12623000601639
Not Applicable
Recruiting
Trial Details
Australian New Zealand Clinical Trials Registry โ€ข ANZCTR12623000601639
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Optimising self-management in people living with chronic kidney disease (CKD:) The Kidney Health 4 Life program
A randomised controlled trial assessing the effectiveness of the Kidney Health for Life (KH4L) program in improving self-management in people living with chronic kidney disease at key stages.

Study Focus

Chronic Kidney Disease

Interventional

Sponsor & Location

Kidney Health Australia

The Australian Kidney Foundation (t/a Kidney Health Australia)

Australia

Timeline & Enrollment

Not Applicable

Aug 14, 2023

Oct 31, 2023

Primary Outcome

Self-management will be measured using the validated Australian CKD Self-Management Instrument (Aus.CKD-SM).

Summary

This randomized controlled trial (RCT) aims to evaluate the effectiveness of the Kidney Health for Life (KH4L) program in improving self-management for people living with chronic kidney disease (CKD), at two key stages: the time of diagnosis and after starting dialysis. Participants will be stratified into two groups, people who have been diagnosed with stage 1-4 CKD and people who have started dialysis in the past year. Participants of both groups will then be randomised to receive the intervention (KH4L program) or standard support (control). Participants will be assessed at three time points, at baseline, week 6 and week 18 post randomisation. We hypothesise that (1) participants in intervention groups will show greater self-management behaviours, disease-related knowledge, self-efficacy, and psychological well-being than participants in the control groups and over time, and (2) disease related knowledge, self-efficacy, psychological well-being and selected sociodemographic variables will be predictors of self-management behaviours. We will also ask participants of the intervention groups to provide some general feedback on the intervention. While this will not be a specific outcome of the study, it will be useful to consider their feedback on how they found the intervention so as to provide guidance for future adjustments to the program, post study. Throughout the course of the study, we will monitor adherence to the intervention by monitoring usage of the KH4L online health hub and record attendance at group sessions. The research team will oversee module completion and activate reminders to those who are lagging on module completion.

ICD-10 Classifications

Chronic kidney disease
Chronic kidney disease, unspecified
Chronic kidney disease, stage 1
Chronic kidney disease, stage 4
Chronic kidney disease, stage 2

Data Source

Australian New Zealand Clinical Trials Registry

ANZCTR12623000601639

Non-Device Trial